Development of anti-‐Leishmaniavaccines…
263
protective immunity against visceral leishmaniasis in mice. Vaccine
25
, 2168-‐2172
(2007).
86 Dondji, B.; Perez-‐Jimenez, E.; Goldsmith-‐Pestana, K.; Esteban, M.; McMahon-‐Pratt, D.
Heterologous prime-‐boost vaccination with the LACK antigen protects against murine
visceral leishmaniasis. Infectionand Immunity
73
, 5286-‐5289(2005).
87 Gonzalo, R. M.; Rodriguez, J. R.; Rodriguez, D.; Gonzalez-‐Aseguinolaza, G.; Larraga, V.;
Esteban, M. Protective immune response against cutaneous leishmaniasis by
prime/booster immunization regimens with vaccinia virus recombinants expressing
Leishmania infantum
p36/LACKand IL-‐12 incombinationwithpurifiedp36.Microbes and
Infection
3
, 701-‐711(2001).
88 Gonzalo, R. M.; del Real, G.; Rodriguez, J. R.; Rodriguez, D.; Heljasvaara, R.; Lucas, P.;
Larraga, V.; Esteban, M. A heterologous prime-‐boost regime using DNA and recombinant
vaccinia virus expressing the
Leishmania infantum
P36/LACK antigen protects BALB/c
mice fromcutaneous leishmaniasis. Vaccine
20
, 1226-‐1231(2002).
89 Ramos, I.; Alonso, A.; Marcen, J. M.; Peris, A.; Castillo, J. A.; Colmenares, M.; Larraga, V.
Heterologous prime-‐boost vaccinationwith a non-‐replicative vaccinia recombinant vector
expressing LACK confers protection against canine visceral leishmaniasis with a
predominantTh1-‐specific immune response. Vaccine
26
, 333-‐344(2008).
90 Dondji, B.; Deak, E.; Goldsmith-‐Pestana, K.; Perez-‐Jimenez, E.; Esteban, M.; Miyake, S.;
Yamamura, T.; McMahon-‐Pratt, D. Intradermal NKT cell activation during DNApriming in
heterologous prime-‐boost vaccination enhances T cell responses and protection against
Leishmania
. European Journal of Immunology
38
, 706-‐719(2008).
91 Ramos, I.; Alonso, A.; Peris, A.; Marcen, J. M.; Abengozar, M. A.; Alcolea, P. J.; Castillo, J. A.;
Larraga, V. Antibiotic resistance free plasmidDNAexpressing LACKprotein leads towards
a protective Th1 response against
Leishmania infantum
infection. Vaccine
27
, 6695-‐6703
(2009).
92 Sanchez-‐Sampedro, L.; Gomez, C. E., Mejias-‐Perez, E.; Sorzano, C. O.; Esteban, M. High
quality long-‐term CD4+ and CD8+ effector memory populations stimulated by DNA-‐
LACK/MVA-‐LACK regimen in
Leishmania major
BALB/c model of infection. PLoS One.
7
,
e38859(2012).
93 Perez-‐Jimenez, E.; Kochan, G.; Gherardi, M. M.; Esteban, M. MVA-‐LACK as a safe and
efficient vector for vaccination against leishmaniasis. Microbes and Infection
8
, 810-‐822
(2006).
94 Tapia, E.; Perez-‐Jimenez, E.; Lopez-‐Fuertes, L.; Gonzalo, R.; Gherardi,M.M.; Esteban,M. The
combination of DNA vectors expressing IL-‐12 + IL-‐18 elicits high protective immune
response against cutaneous leishmaniasis after priming with DNA-‐p36/LACK and the
cytokines, followed by a boosterwith a vaccinia virus recombinant expressing p36/LACK.
Microbes and Infection
5
, 73-‐84(2003).
95 Ramiro, M. J.; Zarate, J. J.; Hanke, T.; Rodriguez, D.; Rodriguez, J. R.; Esteban, M.; Lucientes,
J.; Castillo, J. A.; Larraga, V. Protection in dogs against visceral leishmaniasis caused by
Leishmania infantum
is achieved by immunization with a heterologous prime-‐boost
regime using DNA and vaccinia recombinant vectors expressing LACK. Vaccine
21
, 2474-‐
2484(2003).
96 Dominguez-‐Bernal, G.; Horcajo, P.; Orden, J. A.; De La Fuente, R.; Herrero-‐Gil, A.; Ordonez-‐
Gutierrez, L.; Carrion, J. Mitigating an undesirable immune response of inherent
susceptibility to cutaneous leishmaniosis in amousemodel: the role of the pathoantigenic
HISA70DNAvaccine. VeterinaryResearch
43
, 59(2012).
97 Parody, N.; Soto,M.; Requena, J.M.; Alonso, C. Adjuvant guidedpolarizationof the immune
humoral response against a protective multicomponent antigenic protein (Q) from
Leishmania infantum
. A CpG + Q mix protects Balb/c mice from infection. Parasite
Immunology
26
, 283-‐293(2004).
98 Molano, I.; Alonso, M. G.; Miron, C.; Redondo, E.; Requena, J. M.; Soto, M.; Nieto, C. G.;
Alonso, C. A
Leishmania infantum
multi-‐component antigenic proteinmixedwith live BCG
confers protection to dogs experimentally infected with
L. infantum
. Veterinary
Immunology Immunopathology
92
, 1-‐13(2003).
99 Carcelen, J.; Iniesta, V.; Fernandez-‐Cotrina, J.; Serrano, F.; Parejo, J. C.; Corraliza, I.;
Gallardo-‐Soler, A.; Marañon, F.; Soto, M.; Alonso, C.; Gomez-‐Nieto, C. The chimerical multi-‐
component Qprotein from
Leishmania
in the absenceof adjuvant protects dogs against an
experimental
Leishm nia i fantum
infection. Vaccine.
27
, 5964-‐5973(2009).
